ROLE OF SERUM ONCOSTATIN M IN ASSESSMENT OF DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE PATIENTS

Serum Osteoprotegerin (OPG) as a Potential Biomarker for Disease Activity in Ulcerative Colitis

Serum IL-22 as a Novel Non-Invasive Biomarker in Diagnosis and Assessment of Activity in Ulcerative Colitis Patients

Interleukin-23 as a Predictor of Activities in Inflammatory Bowel Disease

Serum Beta 2-Microglobulin as a Biomarker of Activity in Ulcerative Colitis

Interleukin-6 as a reliable biomarker for inflammatory bowel diseases

Serum Amyloid A as a Biomarker of Ulcerative Colitis Disease Activity

STUDY OF SERUM LONG NON CODING RNAINTERFERON GAMMA ANTISENSE-1 AS BIOMARKER OF ACTIVITY IN CROHN’S DISEASE

STUDY OF CHANGES IN THE SERUM LEVELS OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ( GMCSF ) AND INTERLEUKIN ONE BETA (IL-I B) IN COLONIC CANCER

Association between Serum Level of Oncostatin M and Development of Acute Kidney Injury among Critically Hospitalized Patients and its Role as a Predictive Biomarker